Antibody-selected variation and reversion in Sindbis virus neutralization epitopes. 1986

D S Stec, and A Waddell, and C S Schmaljohn, and G A Cole, and A L Schmaljohn

Sindbis virus variants evidencing a complex and bidirectional tendency toward spontaneous antigenic change were isolated and characterized. Variants were selected on the basis of their escape from neutralization by individual monoclonal antibodies to either of the two envelope glycoproteins, E2 and E1. Multisite variants, including one altered in three neutralization sites, were obtained by selecting mutants consecutively in the presence of different neutralizing monoclonal antibodies. Two phenotypic revertants, each of which reacquired prototype antigenicity, were back-selected on the basis of their reactivity with a neutralizing monoclonal antibody. An incidental oligonucleotide marker distinguished these and the variant from which they arose from parental Sindbis virus and other mutants, thereby confirming that the revertants were true progeny of the antigenic variant. Prototype Sindbis virus and variants derived from it were compared on the basis of their reactivities with each of a panel of monoclonal antibodies; patterns revealed a minimum of five independently mutable Sindbis virus neutralization epitopes, segregating as three antigenic sites (two E2 and one E1).

UI MeSH Term Description Entries
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D009500 Neutralization Tests The measurement of infection-blocking titer of ANTISERA by testing a series of dilutions for a given virus-antiserum interaction end-point, which is generally the dilution at which tissue cultures inoculated with the serum-virus mixtures demonstrate cytopathology (CPE) or the dilution at which 50% of test animals injected with serum-virus mixtures show infectivity (ID50) or die (LD50). Neutralization Test,Test, Neutralization,Tests, Neutralization
D009841 Oligonucleotides Polymers made up of a few (2-20) nucleotides. In molecular genetics, they refer to a short sequence synthesized to match a region where a mutation is known to occur, and then used as a probe (OLIGONUCLEOTIDE PROBES). (Dorland, 28th ed) Oligonucleotide
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D006386 Hemagglutination Tests Sensitive tests to measure certain antigens, antibodies, or viruses, using their ability to agglutinate certain erythrocytes. (From Stedman, 26th ed) Hemagglutination Test,Test, Hemagglutination,Tests, Hemagglutination
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies
D000939 Epitopes Sites on an antigen that interact with specific antibodies. Antigenic Determinant,Antigenic Determinants,Antigenic Specificity,Epitope,Determinant, Antigenic,Determinants, Antigenic,Specificity, Antigenic
D012367 RNA, Viral Ribonucleic acid that makes up the genetic material of viruses. Viral RNA

Related Publications

D S Stec, and A Waddell, and C S Schmaljohn, and G A Cole, and A L Schmaljohn
January 1988, Annals of the New York Academy of Sciences,
D S Stec, and A Waddell, and C S Schmaljohn, and G A Cole, and A L Schmaljohn
September 1983, Infection and immunity,
D S Stec, and A Waddell, and C S Schmaljohn, and G A Cole, and A L Schmaljohn
March 1991, Virology,
D S Stec, and A Waddell, and C S Schmaljohn, and G A Cole, and A L Schmaljohn
January 1987, Advances in experimental medicine and biology,
D S Stec, and A Waddell, and C S Schmaljohn, and G A Cole, and A L Schmaljohn
October 1986, Journal of virology,
D S Stec, and A Waddell, and C S Schmaljohn, and G A Cole, and A L Schmaljohn
March 1977, Infection and immunity,
D S Stec, and A Waddell, and C S Schmaljohn, and G A Cole, and A L Schmaljohn
January 1987, Advances in experimental medicine and biology,
D S Stec, and A Waddell, and C S Schmaljohn, and G A Cole, and A L Schmaljohn
September 2016, The Journal of general virology,
D S Stec, and A Waddell, and C S Schmaljohn, and G A Cole, and A L Schmaljohn
December 2004, Veterinary immunology and immunopathology,
D S Stec, and A Waddell, and C S Schmaljohn, and G A Cole, and A L Schmaljohn
September 1988, Virology,
Copied contents to your clipboard!